undamentalytics Newsletter

Kurzius Lawrence Erik: insider trades

Chief executive, Officer, Director, 10% owner at 3 companies we cover. 7 open-market purchases and 18 sales not made under a pre-set plan, reported from October 26, 2010 to September 17, 2026.

Would copying Kurzius Lawrence Erik’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 2 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on March 12, 2025 into $20,397 by November 2, 2026, +54.5% a year. The copy held shares only 100% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $13,802, +21.7% a year (the S&P 500 held throughout made $13,802, +21.7% a year). Beta against the index was 1.13. Twelve months after each report, the average purchase was +34.4% against the S&P 500 (median +34.4%), and 50% beat it. Measured from the trade date, the insider’s own timing, the average was +30.4%. After their sales, the shares moved −21.4% against the index over 12 months on average (a negative figure means selling was the right call); 86% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$10.0k$20.0k 20252026 $20.4k$13.8k$13.8k
Copying Kurzius Lawrence ErikS&P 500, same days investedS&P 500, held throughout $10,000 copying Kurzius Lawrence Erik’s open-market purchases from March 12, 2025, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+54.5%
S&P 500, same days invested
+21.7% (held throughout +21.7%)
Time in shares
100%
Sharpe ratio (S&P 500)
1.15 (1.01)
Biggest drop (S&P 500)
−28% (−14%)
Market sensitivity (beta)
1.13
Purchases copied
7

Trade by trade

Kurzius Lawrence Erik: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 4 +11.4% +14.2% 75% 1 — — Not enough years
Purchases, 6 months after the report 4 +8.7% +0.9% 50% 1 — — Not enough years
Purchases, 12 months after the report 2 +34.4% +34.4% 50% 1 — — Not enough years
Purchases, 12 months after the trade 2 +30.4% +30.4% 50% 1 — — Not enough years
Sales, 3 months after the report 17 −7.2% −4.7% 59% 11 −2.29 0.045 Some evidence: seller right
Sales, 12 months after the report 14 −21.4% −18.4% 86% 10 −2.54 0.032 Some evidence: seller right
Sales, 12 months after the trade 14 −21.7% −19.8% 86% 10 −2.55 0.031 Some evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
McCormick & Company MKC Chairman & CEO018October 26, 2010August 12, 2026
The Cooper Companies COO —40September 29, 2025September 17, 2026
Elanco Animal Health Inc ELAN —30March 11, 2025August 21, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
September 17, 2026September 16, 2026 COO Purchase $549,300 not yetnot yetnot yet
September 15, 2026September 14, 2026 COO Purchase $539,200 not yetnot yetnot yet
August 21, 2026August 20, 2026 ELAN Purchase $936,000 not yetnot yetnot yet
August 12, 2026August 10, 2026 MKC Sale $10,829,797 not yetnot yetnot yet
February 13, 2026February 12, 2026 MKC Sale $3,581,500 −40.4%not yetnot yet
January 14, 2026January 13, 2026 MKC Sale $3,371,500 −23.8%not yetnot yet
December 17, 2025December 17, 2025 COO Purchase $165,000 −12.3%not yetnot yet
December 16, 2025December 12, 2025 ELAN Purchase $213,000 +11.5%not yetnot yet
November 12, 2025November 11, 2025 MKC Sale $2,517,964 +3.5%not yetnot yet
October 10, 2025October 8, 2025 MKC Sale $3,293,000 −0.3%−45.8%−46.6%
September 29, 2025September 29, 2025 COO Purchase $136,780 +16.9%−32.2%−32.6%
April 2, 2025April 2, 2025 MKC Sale $4,090,500 −24.1%−59.5%−53.9%
March 11, 2025March 7, 2025 ELAN Purchase $211,000 +29.4%+100.9%+93.5%
February 4, 2025February 3, 2025 MKC Sale $3,840,500 +5.0%−25.6%−28.6%
July 17, 2024July 17, 2024 MKC Sale $1,875,000 +4.2%−15.3%−17.1%
May 22, 2024May 21, 2024 MKC Sale $5,900,000 +3.3%−11.9%−12.1%
May 16, 2023May 12, 2023 MKC Sale $3,592,338 −9.2%−44.1%−44.5%
October 25, 2022October 24, 2022 MKC Sale $372,075 −8.8%−25.1%−23.8%
February 1, 2022January 28, 2022 MKC Sale $9,831,300 +4.1%−17.0%−15.6%
August 11, 2020August 7, 2020 MKC Sale $10,120,000 −14.8%−47.7%−49.8%
October 31, 2018October 30, 2018 MKC Sale $7,285,113 −14.1%−3.9%−2.9%
August 19, 2014August 18, 2014 MKC Sale $4,506,190 +1.3%+16.1%+16.8%
April 23, 2013April 19, 2013 MKC Sale $6,040,800 −6.8%−19.7%−22.6%
October 3, 2012October 1, 2012 MKC Sale $6,390,713 +4.0%−9.9%−13.6%
October 26, 2010October 22, 2010 MKC Sale $3,457,000 −4.7%+9.3%+10.7%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Kurzius Lawrence Erik traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.